AAAAAA

   
Results: 1-21 |
Results: 21

Authors: VANMEYEL DJ SANCHEZSWEATMAN OH KERKVLIET N STITT L RAMSAY DA KHOKHA R CHAMBERS AF CAIRNCROSS JG
Citation: Dj. Vanmeyel et al., GENETIC BACKGROUND INFLUENCES TIMING, MORPHOLOGY AND DISSEMINATION OFLYMPHOMAS IN P53-DEFICIENT MICE, International journal of oncology, 13(5), 1998, pp. 917-922

Authors: SCHMIDT EE LUZZI KJ MACDONALD IC KERKVLIET N MORRIS VL GROOM AC CHAMBERS AF
Citation: Ee. Schmidt et al., METASTATIC INEFFICIENCY IN MOUSE-LIVER - DORMANCY OF MOST MELANOMA-CELLS AFTER EXTRAVASATION, AND LOSS OF EARLY MICROMETASTASES, The FASEB journal, 12(4), 1998, pp. 223-223

Authors: TUCK AB OMALLEY FP SINGHAL H HARRIS JF TONKIN KS KERKVLIET N SAAD Z DOIG GS CHAMBERS AF
Citation: Ab. Tuck et al., OSTEOPONTIN EXPRESSION IN A GROUP OF LYMPH-NODE NEGATIVE BREAST-CANCER PATIENTS, International journal of cancer, 79(5), 1998, pp. 502-508

Authors: LUZZI KJ MACDONALD IC SCHMIDT EE KERKVLIET N MORRIS VL CHAMBERS AF GROOM AC
Citation: Kj. Luzzi et al., MULTISTEP NATURE OF METASTATIC INEFFICIENCY - DORMANCY OF SOLITARY CELLS AFTER SUCCESSFUL EXTRAVASATION AND LIMITED SURVIVAL OF EARLY MICROMETASTASES, The American journal of pathology, 153(3), 1998, pp. 865-873

Authors: TWEEDIE E TONKIN K KERKVLIET N DOIG GS SPARROW RK OMALLEY FP
Citation: E. Tweedie et al., BIOLOGIC CHARACTERISTICS OF BREAST-CANCER DETECTED BY MAMMOGRAPHY ANDBY PALPATION IN A SCREENING-PROGRAM - A PILOT-STUDY, Clinical and investigative medicine, 20(5), 1997, pp. 300-307

Authors: MACK L KERKVLIET N DOIG G OMALLEY FP
Citation: L. Mack et al., RELATIONSHIP OF A NEW HISTOLOGICAL CATEGORIZATION OF DUCTAL CARCINOMAIN-SITU OF THE BREAST WITH SIZE AND THE IMMUNOHISTOCHEMICAL EXPRESSION OF P53, C-ERB B2, BCL-2, AND KI-67, Human pathology, 28(8), 1997, pp. 974-979

Authors: ALANEN K ELIT L KERKVLIET N SMITH E MCLACHLIN CM
Citation: K. Alanen et al., THE UTILITY OF HYBRID CAPTURE HPV TESTING AS AN ADJUNCT TO FOLLOW-UP OF PATIENTS WITH ASCUS LSIL PAP SMEARS/, Laboratory investigation, 76(1), 1997, pp. 163-163

Authors: RAYMOND L ELIT L KERKVLIET N MCLACHLIN CM
Citation: L. Raymond et al., EVALUATION OF HYBRID CAPTURE HPV TESTING AS AN AID TO THE MANAGEMENT OF COLPOSCOPY PATIENTS, Laboratory investigation, 76(1), 1997, pp. 203-203

Authors: RODENHISER D OMALLEY FP MANCINI D AINSWORTH P SINGH S CHAKRABORTY P KERKVLIET N
Citation: D. Rodenhiser et al., EVALUATING DNA METHYLATION PATTERNS AT MUTATIONAL HOTSPOTS USING ARCHIVAL TISSUES, Laboratory investigation, 76(1), 1997, pp. 1080-1080

Authors: CHAMBERS AF WILSON SM KERKVLIET N OMALLEY FP HARRIS JF CASSON AG
Citation: Af. Chambers et al., OSTEOPONTIN EXPRESSION IN LUNG-CANCER, Lung cancer, 15(3), 1996, pp. 311-323

Authors: ENGEL CJ BENNETT ST CHAMBERS AF DOIG GS KERKVLIET N OMALLEY FP
Citation: Cj. Engel et al., TUMOR ANGIOGENESIS PREDICTS RECURRENCE IN INVASIVE COLORECTAL-CANCER WHEN CONTROLLED FOR DUKES STAGING, The American journal of surgical pathology, 20(10), 1996, pp. 1260-1265

Authors: OMALLEY FP SAAD Z KERKVLIET N DOIG G STITT L AINSWORTH P HUNDAL H CHAMBERS AF TURNBULL DI BRAMWELL V
Citation: Fp. Omalley et al., THE PREDICTIVE POWER OF SEMIQUANTITATIVE IMMUNOHISTOCHEMICAL ASSESSMENT OF P53 AND C-ERB B-2 IN LYMPH NODE-NEGATIVE BREAST-CANCER, Human pathology, 27(9), 1996, pp. 955-963

Authors: MACK L KERKVLIET N DOIG GS OMALLEY FP
Citation: L. Mack et al., RELATIONSHIP OF A NEW HISTOLOGIC CATEGORIZATION OF DCIS OF THE BREASTAND THE IMMUNOHISTOCHEMICAL EXPRESSION OF P53, C-ERB B2, BCL-2, AND KI67, Laboratory investigation, 74(1), 1996, pp. 97-97

Authors: OMALLEY FP HARRIS JF DOIG GS KERKVLIET N SAAD Z BAUTISTA D TONKIN K CHAMBERS AF
Citation: Fp. Omalley et al., OSTEOPONTIN EXPRESSION IS AN INDEPENDENT PROGNOSTIC INDICATOR IN LYMPH-NODE NEGATIVE BREAST-CANCER, Laboratory investigation, 74(1), 1996, pp. 109-109

Authors: TWEEDIE E OMALLEY F TONKIN K KERKVLIET N DOIG G TURNBULL DI MCCURDY L
Citation: E. Tweedie et al., THE BIOLOGY OF BREAST-CANCER DIAGNOSED THROUGH THE ONTARIO BREAST-CANCER SCREENING-PROGRAM, Laboratory investigation, 72(1), 1995, pp. 27-27

Authors: CASSON AG KERKVLIET N OMALLEY F
Citation: Ag. Casson et al., PROGNOSTIC VALUE OF P53 PROTEIN IN ESOPHAGEAL ADENOCARCINOMA, Journal of surgical oncology, 60(1), 1995, pp. 5-11

Authors: OMALLEY F SAAD Z KERKVLIET N CHAMBERS A TONKIN K TURNBULL I BRAMWELL V
Citation: F. Omalley et al., THE PREDICTIVE POWER OF A COMBINATION OF KI67, C-ERB B2 AND P53 IN LYMPH-NODE NEGATIVE BREAST-CANCER, Laboratory investigation, 70(1), 1994, pp. 10000019-10000019

Authors: CASSON AG KERKVLIET N OMALLEY F INCULET R TROSTER M
Citation: Ag. Casson et al., P53 IMMUNOREACTIVITY IN CARCINOSARCOMA OF THE ESOPHAGUS, Journal of surgical oncology, 56(2), 1994, pp. 132-135

Authors: CASSON AG MCCUAIG S CRAIG I AYED A INCULET R KERKVLIET N OMALLEY F
Citation: Ag. Casson et al., PROGNOSTIC VALUE AND CLINICOPATHOLOGICAL CORRELATION OF P53 GENE-MUTATIONS AND NUCLEAR-DNA CONTENT IN HUMAN LUNG-CANCER - A PROSPECTIVE-STUDY, Journal of surgical oncology, 56(1), 1994, pp. 13-20

Authors: CASSON AG MANOLOPOULOS B TROSTER M KERKVLIET N OMALLEY F INCULET R FINLEY R ROTH JA
Citation: Ag. Casson et al., CLINICAL IMPLICATIONS OF P53 GENE MUTATION IN THE PROGRESSION OF BARRETTS EPITHELIUM TO INVASIVE ESOPHAGEAL CANCER, The American journal of surgery, 167(1), 1994, pp. 52-57

Authors: OMALLEY FP GRIGNON DJ KEENEY M KERKVLIET N MCLEAN C
Citation: Fp. Omalley et al., DNA HETEROGENEITY IN PROSTATIC ADENOCARCINOMA - A DNA FLOW CYTOMETRICMAPPING STUDY WITH WHOLE ORGAN SECTIONS OF PROSTATE, Cancer, 71(9), 1993, pp. 2797-2802
Risultati: 1-21 |